「医薬品等の回収情報」に関する調査・研究―遡及調査の影響―:―遡及調査の影響―
スポンサーリンク
概要
- 論文の詳細を見る
Information concerning recalls of products derived from particular biological sources has been provided in the "Recall Information" section of a website containing information on drugs and medical equipment since July, 2003. However, considering that "products derived from particular biological sources" have mostly been recovered when the information is presented on the website, the quantity of the products for recovery is likely to be substantial based on "State of Progression of Retrospective Investigations of Blood Donors", and that the Red Cross of Japan has provided 24,019 pieces of information to medical organizations in connection with retrospective investigations, recall information concerning "products derived from particular biological sources" differs from that for other products in that its presentation is restricted.However, the situation has been markedly influenced by the following regulations.1. The possibility of retrospective investigation was increased by Article 68-9 of the Pharmaceutical Affairs Law enforced on July 30, 2003 : "Preparation and retention of records on biological products".2)2. The "Exhaustive review of blood donation histories of blood donors"3) stipulated that information must be provided to medical organizations, and the products in question must be recovered if they have not been used.In this study, the usefulness of retrospective investigation of recall information of "products derived from particular biological sources" was evaluated.The results suggest that, in evaluating "recall information", it is necessary to investigate the total number of products to be recalled and the background of the recalls, and also to consider regulations other than the recall regulations applied to individual drugs.
- 日本医療薬学会の論文
日本医療薬学会 | 論文
- O17-003 視覚障害者に対する手技指導の標準化を目的とした視覚障害擬似体験インスリン注射院内実習(一般演題 口頭発表,糖尿病/後発医薬品,医療薬学の創る未来 科学と臨床の融合)
- 20H-16 Basal-Bolus療法におけるインスリンデテミルの有効性(使用状況調査・意識調査,来るべき時代への道を拓く)
- 30-P2-43 2種類のインスリン試薬を用いた化学発光酵素免疫測定法によってFactitious hypoglicemiaを証明しえた一例(副作用・有害事象,社会の期待に応える医療薬学を)
- 28-04-20 ペン型インスリン注射器の精度に及ぼす注入時抵抗とカートリッジ内気泡の影響
- P-610 ファブリー病に対する「ファブラザイム^[○!R]」投与時の「過敏反応発現時の対処方法」の一部改変により副作用防止に至った1症例(8.有害事象・副作用(基礎と臨床)1,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)